Market Cap: $205.49M
CI
Coherus Oncology, Inc.
CHRS
NASDAQ (NASDAQ Global Market)USD
Market Cap: $205.49M
Filed a patent for "anti-ilt4 compositions and methods" on Thu, September 1, 2022
New US PatentFiled a patent for "systems and methods for producing sterile injection devices" on Thu, June 29, 2023
New US PatentFiled a patent for "systems and methods for producing sterile injection devices" on Thu, December 28, 2023
New US PatentFiled a patent for "methods of treating cancer" on Tue, March 29, 2022
New US PatentFiled a patent for "control mechanism for priming an injection device" on Thu, October 27, 2022
New US PatentFiled a patent for "methods of purifying ranibizumab or a ranibizumab variant" on Mon, April 11, 2022
New US PatentFiled a patent for "compositions and methods to treat non-alcoholic fatty liver diseases (nafld)" on Thu, February 29, 2024
New US Patent